SenesTech
Biotechnology · 1 employees
SenesTech is the rodent birth control expert and the only manufacturer of Rat Birth Control®, dedicated to improving global health by safely and humanely managing pest populations. Our product, Evolve™, disrupts reproduction in both male and female rats, using FIFRA Section 25(b) exempt soft baits that pose little to no risk to people, pets, wildlife, or the environment. As part of an Integrated P
Funding history
- Series seed — $274K — Aug 2025
- Series pre-seed — $182K — Jul 2025
- Series seed — $1.5M — Apr 2023
- Series series c — Undisclosed — Aug 2022
- Funding Round — $10.0M — Feb 2021
Recent signals
- May 07, 2026: SenesTech Appoints Michael Edell as President and Chief Executive Officer
- Aug 12, 2025: Raised $274K in Series seed
- Jul 14, 2025: Raised $182K in Series pre-seed
- Oct 31, 2024: Launched SenesTech, Inc. announces the registration of Evolve™ in Hong Kong, offering a humane rodent control solution.
- Apr 26, 2023: Raised $1.5M in Series seed
- Aug 26, 2022: Raised funding in Series series c
- Feb 10, 2021: Raised $10.0M
- Nov 10, 2020: Raised $3.1M
See plans & pricing → Track SenesTech’s funding, hiring, and signals — with verified contacts — on Fundz.